175
Views
8
CrossRef citations to date
0
Altmetric
Brief Report

Resource utilization impact of topiramate for migraine prevention in the managed-care setting*

, , &
Pages 499-503 | Accepted 04 Dec 2008, Published online: 12 Jan 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Robert Cowan, Alit Stark-Inbar, Liron Rabany, Dagan Harris, Maya Vizel, Alon Ironi, Julio R. Vieira, Michelle Galen & Christina Treppendahl. (2023) Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention. Journal of Medical Economics 26:1, pages 656-664.
Read now

Articles from other publishers (7)

Leon S. Moskatel & Niushen Zhang. (2023) The Role of Step Therapy in the Treatment of Migraine. Current Pain and Headache Reports.
Crossref
Machaon BonafedeSandhya SapraNeel ShahStewart TepperKatherine CappellPooja Desai. (2018) Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States. Headache: The Journal of Head and Face Pain 58:5, pages 700-714.
Crossref
Stephen D. Silberstein. (2017) Topiramate in Migraine Prevention: A 2016 Perspective. Headache: The Journal of Head and Face Pain 57:1, pages 165-178.
Crossref
Dawn A. Marcus & Duren Michael ReadyDawn A. Marcus & Duren Michael Ready. 2017. Discussing Migraine With Your Patients. Discussing Migraine With Your Patients 113 133 .
Zsolt Hepp, Noah L Rosen, Patrick G Gillard, Sepideh F Varon, Nitya Mathew & David W Dodick. (2016) Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database. Cephalalgia 36:9, pages 862-874.
Crossref
Jun Wu, Mary D. Hughes, Matthew F. Hudson & Peggy J. Wagner. (2011) Antimigraine medication use and associated health care costs in employed patients. The Journal of Headache and Pain 13:2, pages 121-127.
Crossref
Lars Edvinsson & Mattias Linde. (2010) New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. The Lancet 376:9741, pages 645-655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.